functional liver imaging, there was a statistically significant decrease in the liver phagocytic/reticuloendothelial system function after DM induction, as evidenced by decreased 99m Tc-SC liver uptake and increased blood pool compared to prediabetes, while the hepatobiliary function remained unchanged after DM induction using 99m Tc-BrIDA imaging.
Introduction
Diabetes mellitus (DM) involves abnormalities of the metabolism of glucose in the body, leading to pathophysiologic complications in various organs. Aspects of such pathophysiologic complications in diabetes include a markedly increased mobilization of fats from storage areas, causing abnormal fat metabolism as well as the deposition of cholesterol in arterial walls and atherosclerosis [1] . Fatty infiltration of the liver has also been reported to be linked with diabetes and can be associated with elevated liver enzyme levels such as transaminases and high bilirubin levels [2] [3] [4] [5] . In this study, we investigated the liver function of rat models of DM, using two types of radiopharmaceuticals: technetium-99m-labeled sulfur colloid ( Tc-SC is used routinely to study the function of the phagocytic/reticuloendothelial system, while 99m TcBrIDA is also used routinely to study hepatobiliary function. There has been limited research involving both liver
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Materials and Methods

Radiopharmaceuticals
Mebrofenin (bromo iminodiacetic acid, BrIDA) and SC were purchased as commercial kits from Amersham International plc (Amersham GE, UK).
99m Tc-SC and 99m Tc-BrIDA were prepared according to the manufacturer's recommendations. All other chemicals used in this study were purchased and supplied by Sigma-Aldrich (UK).
Experimental Animals
Adult male Sprague-Dawley rats (250 8 50 g body weight) bred at the animal facility of the Faculty of Medicine, Kuwait University, were used in this study (n = 40). The animals had free access to water and food and were handled in accordance with an established animal use protocol following recommendations of the Helsinki Declaration and Kuwait University's institutional animal care and use committee.
Induction of Diabetes in Rats and Blood Glucose Assay
DM was induced in the rats by intraperitoneal injection of 55 mg/kg body weight streptozotocin (STZ) freshly dissolved in 5 mmol/l citrate buffer at a pH of 4.5 [6, 7] . Blood was tested before the induction of diabetes for basal glucose determination, and 2 and 7 days after the induction of diabetes using the FreeStyle Freedom Lite blood glucose monitoring system (Abbott Laboratories, Ill., USA). All rats showed elevated glucose levels equal to or higher than 11 mmol/l after having received the induction protocol.
Experimental Protocol
The 40 rats were divided into 2 equal groups for 99m Tc-SC and 99m Tc-BrIDA imaging. As a prediabetes baseline study, 99m Tc-SC and 99m Tc-BrIDA imaging were performed on all animals. At 1 week after induction of diabetes, both 99m Tc-SC and 99m Tc-BrIDA imaging was repeated using the same imaging protocol.
Imaging Protocol
The rats were anesthetized using an intraperitoneal injection of ketamine:xylazine (40 mg/kg:5 mg/kg body weight; Serumwerk Bernburg, Germany), and an intravenous line Butterfly 21G IV catheter (Medi Move Ltd., UK) was placed in the dorsal tail vein for radiopharmaceutical injection.
The rats were positioned face up, and an anterior view of whole body (WB) was taken using a large-field-of-view, 40 ! 60 cm clinical gamma camera (Philips camera, Odyssey LX; Philips, UK) fitted with a low-energy, all-purpose, parallel-hole collimator connected to a data acquisition computer. Imaging involved 2 dynamic phases, a vascular phase of 1 s/frame for 1 min, followed by a parenchymal phase at 1 min/frame for 1 h after the injection of 37
MBq of 99m
Tc-SC or 99m TC-BrIDA. Images were acquired in a 64 ! 64 pixel matrix, using a photopeak centered at 140 keV with a symmetric 20% window and zoom of 4. The pinhole collimator was not used because quantitative analysis could not be applied and the parallel hole collimator was suitable for this purpose.
Image Processing
On a 0-to 61-min composite image, the regional distribution of the radiotracer was determined by drawing regions of interest (ROI) over the heart, liver, spleen and WB for 99m Tc-SC ( fig. 1 a) , and over the liver, liver parenchyma, bile in the liver hilum, abdomen and WB for 99m Tc-BrIDA ( fig. 1 b) . The following ratios were obtained: heart, liver or spleen to WB for 99m Tc-SC, and liver, biliary tree, liver parenchyma or abdominal cavity to WB for 99m TcBrIDA for both baseline and diabetic rat scans. These ratios represent the percentage of radioactivity uptake in each organ compared to the WB counts accumulated over 60 min. In addition, a ratio before and after DM for each organ was calculated. The anterior view was adequate for imaging the organs of interest, i.e. the heart, liver and spleen.
Data Presentation and Statistical Analysis
All data, unless otherwise stated, are expressed as means 8 SD. The paired t test was used to evaluate differences between baseline control and diabetic rats. Statistical analysis was performed using the SPSS software, version 13 (SSPS Inc., Chicago, Ill., USA).
Results
Induction of Diabetes and Blood Glucose Assays
The average blood glucose level was 5.7 8 1.2 mmol/l at baseline, 15.7 8 1.1 mmol/l at 48 h and 27.7 8 1.4 mmol/l at 1 week after DM induction in all animals. In the diabetic rats, there was a significant loss of body weight from 250 8 50 to 138 8 40 g (p ! 0.05).
Functional Imaging
The time activity curves from 0 to 61 min for a preand post-DM 99m Tc-SC study of the heart, liver and spleen are given in figure 2 . The cardiac time activity curve shows a rapid decline, while the liver and spleen show a fast uptake up to a peak at 5 min. A similar pattern was seen in DM rats. The uptake ratios for 99m Tc-SC are shown in table 1 for both baseline (control) and DM rats, and the ratios before and after DM for each organ as prediabetic divided by diabetic (D/P) ratio. There is a significantly reduced cardiac blood pool clearance (p = 0.026) and significantly reduced hepatic SC uptake (p = 0.026) in diabetic rats in comparison to the baseline state. Besides, the D/P ratio was significant (p = 0.026) for the heart (1.27) and liver (0.92), but not significant (p = 0.22) for the spleen (1.17).
In figure 2 b, images and time activity curves for a preand post-DM 99m Tc-BrIDA study are displayed, showing the hepatic uptake and biliary excretion of radiotracer. The uptake ratios of liver, bile, liver parenchyma and abdomen to WB (mean 8 SD) between prediabetic and diabetic rats, and the D/P ratio for each organ are shown in table 2 . Using paired t test, the results do not show significant differences between before and after DM induction and the D/P ratio for each organ (p = 0.41).
Discussion
This study examined the use of TcBrIDA study ( b ). Hrtc = Heart control; Hrtd = heart diabetic; Lvrc = liver control; Lvrd = liver diabetic; Splnc = spleen control; Splnd = spleen diabetic; Biliaryc = biliary tree control; Biliaryd = biliary tree diabetic. system function in a similar way to that seen with early cirrhosis, portal hypertension or nonspecific liver damage [8] [9] [10] . The spleen uptake increased slightly after diabetes induction, but did not reach statistical significance in line with a mild colloid shift from liver to spleen. In contrast, 99m
Tc-BrIDA uptake and the kinetics found in the diabetic rats in this study did not show significant differences compared to baseline prediabetic cases, especially in the liver-, bile-, liver-parenchyma-and abdomento-WB ratios. The implication of this finding is that early diabetes may not induce changes in he patobiliary function in terms of uptake and secretion of the radiotracer. In one study in the literature, increased total hepatobiliary bile acid excretion was noted as an effect of STZ-induced diabetes compared to controls [2] , which was also seen in our study (higher bile ratio, although not statistically significant). Our experimental setting did not allow for adequate evaluation of the biliary tree. It is not possible to accurately outline the biliary structures for analysis. However, measurement of the bile excreted in the bowel in the abdomen ROI and liver parenchyma did not show a significant difference between baseline and diabetes and the D/P ratio for each organ (p = 0.41) ( table 2 ).
Conclusion
Our study showed a delayed cardiac blood pool clearance of 99m Tc-SC by the liver, indicating a probable impairment of phagocytes. However, the clearance of concomitantly reduced hepatic 99m Tc-BrIDA was not different in diabetic compared to prediabetic rats, possibly indicating that STZ did not adversely affect the hepatocytes. Difference between prediabetic and diabetic rats (n = 20). * p = 0.026, significant; ** p = 0.22, not significant. 
